Deerfield Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
O
FLAM
AC
KLP
DCM
Deerfield Management's NPCE Position: Q3 2025 in Review
Deerfield Management sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 500,000 shares — an estimated $5.57M sold.
Deerfield Management first reported a position in NPCE in Q1 2025 and held it in 2 quarters. The position peaked at $6.14M in Q1 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.
- Deerfield Management reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
- Deerfield Management sold 500,000 Neuropace shares in Q3 2025, an estimated $5.57M.
- Deerfield Management first reported a position in Neuropace in Q1 2025 and held it in 2 quarters.
- Deerfield Management's Neuropace position peaked at $6.14M in Q1 2025.
- 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.
Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.